Results 1 to 10 of about 4,839 (221)

Adsorption of Proteins on m-CPPD and Urate Crystals Inhibits Crystal-Induced Cell Responses: Study on Albumin-Crystal Interaction

Journal of Functional Biomaterials, 2019
The biological effects and cellular activations triggered by monosodium urate (MSU) and calcium pyrophosphate dihydrate (monoclinic: m-CPPD) crystals might be modulated by protein coating on the crystal surface.
Thibaut Léger, Frédéric Lioté, Jean-Michel Camadro   +2 more
exaly   +3 more sources

When can calcium pyrophosphate deposition disease be considered a polymyalgia rheumatica mimicking disease? [PDF]

Rheumatology
Introduction Similarly to polymyalgia rheumatica (PMR), calcium pyrophosphate deposition (CPPD) disease is common among older people. Calcium pyrophosphate deposition can present in several forms, including proximal manifestations associated with raised ...
Ciro Manzo, Paolo Falsetti, Alberto Castagna, Marco Isetta, Edoardo Conticini   +4 more
doaj   +2 more sources

Which are the most frequently involved peripheral joints in calcium pyrophosphate crystal deposition at imaging? A systematic literature review and meta-analysis by the OMERACT ultrasound – CPPD subgroup

Frontiers in Medicine, 2023
ObjectivesTo identify the prevalence of calcium pyrophosphate crystal deposition (CPPD) using ultrasound and conventional radiology at peripheral joints in patients with suspected or definite CPPD.MethodsA systematic literature search was performed in ...
Antonella Adinolfi, Sirotti Silvia, Garifallia Sakellariou   +2 more
exaly   +3 more sources

Calcium pyrophosphate deposition (CPPD) disease – Treatment options

Best Practice and Research in Clinical Rheumatology, 2021
In contrast to gout, no disease-modifying therapies currently exist that reduce articular crystal deposition of calcium pyrophosphate crystals (CPPs). Treatment is aimed at ameliorating the inflammatory response and reducing the frequency and severity of clinical symptoms due to CPP deposition (CPPD).
John R Stack
exaly   +3 more sources

Diagnosis and Treatment of Calcium Pyrophosphate Deposition (CPPD) Disease: A Review

Open Access Rheumatology: Research and Reviews, 2023
Sharon Cowley, Geraldine McCarthy Department of Rheumatology, Mater Misericordiae University Hospital, Dublin, IrelandCorrespondence: Sharon Cowley, Mater Misericordiae University Hospital, Dublin, Ireland, Email sharoncowley111@gmail.comAbstract ...
Cowley S, McCarthy G
exaly   +2 more sources

Lumbar Intraspinal Calcium Pyrophosphate Deposition: A Comprehensive Case Study [PDF]

Journal of Central Nervous System Disease
Introduction Calcium pyrophosphate deposition (CPPD) disease is characterized by calcium pyrophosphate crystals in hyaline and fibrocartilage. Chondrocalcinosis, a radiographic hallmark for CPPD, becomes more prevalent with age.
Juan M. López-Navarro, Diego A. Sandoval-Lopez, Pavle Popovic, Vasileios Karantzoulis, Zeid Bittar, Edgar Santos, Farzam Vazifehdan   +6 more
doaj   +2 more sources

Therapy for CPPD: Options and Evidence

Current Rheumatology Reports, 2018
Current evidence and accumulated experience for the management of calcium pyrophosphate deposition disease (CPPD) are presented.Contrary to other rheumatic inflammatory conditions that account for high interest and growing research, advances in treating CPPD are still very limited and mostly derive from those achieved in gout.
Mariano Andrés, Francisca Sivera, Eliseo Pascual   +2 more
exaly   +6 more sources

Imaging of the Entry Pathway of a Cell-Penetrating Peptide–DNA Complex From the Extracellular Space to Chloroplast Nucleoids Across Multiple Membranes in Arabidopsis Leaves

Frontiers in Plant Science, 2021
Each plant cell has hundreds of copies of the chloroplast genome and chloroplast transgenes do not undergo silencing. Therefore, chloroplast transformation has many powerful potential agricultural and industrial applications.
Kazusato Oikawa, Ayaka Tateishi, Masaki Odahara, Yutaka Kodama, Yutaka Kodama, Keiji Numata, Keiji Numata   +6 more
doaj   +1 more source

Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy

Терапевтический архив, 2023
Background. Calcium pyrophosphate crystal deposition disease (CPPD) may be associated with developing of diastolic dysfunction (DD). Aim. To determine the variability of echocardiographic parameters in patients with CPPD receiving anti-inflammatory ...
Maxim S. Eliseev, Olga V. Zheliabina, Irina G. Kirillova, Yulia O. Korsakova   +3 more
doaj   +1 more source

Advances in imaging for the assessment of calcium pyrophosphate deposition disease [PDF]

Beyond Rheumatology, 2022
Calcium pyrophosphate (CPP) deposition (CPPD) disease is a common form of inflammatory arthritis. Despite its prevalence, it’s an under-studied condition and its diagnosis is still challenging.
S. Sirotti, P. Sarzi-Puttini, G. Filippou   +2 more
doaj   +1 more source